Comparative characteristics of eye drops used for the treatment of glaucoma in an experimental model of dry eye
https://doi.org/10.21516/2072-0076-2025-18-2-116-122
Abstract
Purpose of the work is a comparative study of the effect of different concentrations of the excipient carbomer on the local bioavailability and local irritant effect of brinzolamide and timolol in an experimental model of dry eye syndrome (DES). Material and methods. The study was performed on 35 sexually mature male rabbits of the Soviet Chinchilla breed. The effect of Brinarga eye drops (INN brinzolamide + timolol) containing carbomer 4.2 mg as an excipient (Sentiss Pharma Pvt. Ltd., India) and the comparison drugs — Preparation 1 (original) and Preparation 2 (generic, European manufacturer), containing INN brinzolamide + timolol and carbomer 4.0 mg, when instilled into the conjunctival sac every 12 hours for 14 days was studied. The local irritant effect of eye drops on the cornea of the eye and the bioavailability of the active substances included in all the studied drops were assessed on an experimental model of dry eye syndrome, which was reproduced by daily instillation of 1 drop of 1 % atropine sulfate into experimental animals 3 times a day for 5 days. Results. It was found that Brinarga eye drops containing 4.2 mg/ml carbomer 974P do not aggravate the course of DES and do not have a local irritant effect. On the contrary, their use is accompanied by a partial correction of the pathological condition (although it does not lead to complete restoration of corneal moisture to the values of the intact eye), unlike the existing analogs — Preparation 1 and Preparation 2, containing carbomer 974P at a concentration of 4.0 mg/ml. At the same time, Preparation 2 (generic, European manufacturer) caused a pronounced local irritant effect (total score 7.2 ± 1.2), which led to its early exclusion from the experiment. At 60 min, the maximum measured concentration of brinzolamide and timolol (Brinarga) in the aqueous humor of the anterior chamber during DES significantly exceeded that of Preparation 1 and Preparation 2. Conclusion. Increasing the concentration of carbomer to 4.2 mg/ml facilitates the passage of brinzolamide/timolol (Brinarga) through the tissue barrier of the eye and prevents presystemic elimination due to imparting optimal viscometric characteristics to the dosage form.
About the Authors
E. V. BlinovaRussian Federation
Ekaterina V. Blinova — Dr. of Med. Sci., professor, professor of chair of clinical pharmacology and internal diseases propaedeutic, N.V. Sklifosovsky Institute of Clinical Medicine.
8/2, Trubetskaya St., Moscow, 119991
E. A. Litvin
Russian Federation
Evgeny A. Litvin — Cand. of Biol. Sci., senior researcher of laboratory of pharmacology and healthcare technology assessment.
1, Samora Mashel St., Moscow, 117997
D. S. Blinov
Russian Federation
Dmitry S. Blinov — Dr. of Med. Sci., associate professor, head of the laboratory of pharmacology healthcare technology assessment.
1, Samora Mashel St., Moscow, 117997
A. A. Galchin
Russian Federation
Alexander A. Galchin — Cand. of Med. Sci., deputy director of the engineering and physics, institute of biomedicine.
31, Kashirskoe Hgwy, Moscow, 115409
M. V. Shikh
Russian Federation
Maksim V. Shikh — Master.
5, Bldg. 1, 2nd Baumanskaya St., Moscow, 105005
I. S. Struts
Russian Federation
Ivar S. Struts — 4th year student.
8/2, Trubetskaya St., Moscow, 119991
K. D. Blinov
Russian Federation
Kirill D. Blinov — 2th year student.
8/2, Trubetskaya St., Moscow, 119991
S. D. Yudina
Russian Federation
Sof’ya D. Yudina — 2th year student.
8/2, Trubetskaya St., Moscow, 119991
O. V. Sergeeva
Russian Federation
Olga V. Sergeeva — Cand. of Med. Sci., associate professor of chair of fundamental medicine.
31, Kashirskoe Hgwy, Moscow, 115409
S. E. Zotov
Russian Federation
Sergey E. Zotov — 5th year student.
8/2, Trubetskaya St., Moscow, 119991
E. V. Shikh
Russian Federation
Evgeniia V. Shikh — Dr. of Med. Sci., professor, head of chair of clinical pharmacology and internal diseases propaedeutic, N.V. Sklifosovsky Institute of Clinical Medicine.
8/2, Trubetskaya St., Moscow, 119991
References
1. Gorenkov R.V., Ryabtseva A.A., Agafonov B.V., et al. Dry eye syndrome in general medical practice. Effective pharmacotherapy. 2019; 15 (33): 30–6 (In Russ.).
2. Qian L, Wei W. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS One. 2022 Aug 19; 17 (8):e0271267. doi: 10.1371/journal.pone.0271267
3. Craig JP, Nichols KK, Ak pek EK,et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017 Jul; 15 (3): 276–83. doi: 10.1016/j.jtos.2017.05.008
4. Murube J, Wilson St, Ramos-Esteban J. The important developments in dry eye. Highlights of Ophthalmology. 2001; 29 (5): 54–66.
5. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007 Apr; 5 (2): 75–92. doi: 10.1016/s1542-0124(12)70081-2
6. Boiko E.V., Simakova I.L., Yakushev D.Yu., et al. Dry eye syndrome in patients with primary open-angle glaucoma. Vestnik oftal’mologii. 2015; 131 (3): 22–6 (In Russ.). https://doi.org/10.17116/oftalma2015131322-26
7. Xiao Q, Hu Y, Chen F, Chen X. A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes. J Huazhong Univ Sci Technolog Med Sci. 2008 Oct; 28 (5): 592–5. doi: 10.1007/s11596-008-0523-9
8. Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999; 31 (3): 229–35. doi: 10.1159/000055537
9. Blinova E.V., Poluosmak G.K., Litvin E.A., et al. Hypromellose improves mydriasis dynamics by phenylephrine in a rabbit experimental model. Russian ophthalmological journal. 2023; 16 (1): 119–26 (In Russ.). https://doi.org/10.21516/2072-0076-2023-16-1-119-126
Review
For citations:
Blinova E.V., Litvin E.A., Blinov D.S., Galchin A.A., Shikh M.V., Struts I.S., Blinov K.D., Yudina S.D., Sergeeva O.V., Zotov S.E., Shikh E.V. Comparative characteristics of eye drops used for the treatment of glaucoma in an experimental model of dry eye. Russian Ophthalmological Journal. 2025;18(2):116-122. (In Russ.) https://doi.org/10.21516/2072-0076-2025-18-2-116-122